BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today highlighted its recent pipeline ...

Rohit Chopra, who led the Consumer Financial Protection Bureau, was known for his aggressive enforcement and expansion of consumer protection laws. By Stacy Cowley The director of the Consumer ...

Initial data for the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in second quarter of 2025 Dosing in the Heart-2 trial has moved to the 0.6 mg/kg cohort VERVE-301 ...

Consumer spending will play a large role in the economy in 2025, as it always does. However, the impact has often been overstated. Nonetheless, the strong footing of households—in the aggregate ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for ... after the company spun off its consumer health unit in 2023.

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

China's CPI rose 0.2% in 2024 Factory-gate prices deflationary for 27 months Stimulus impact seen as short-lived BEIJING, Jan 9 (Reuters) - China's consumer prices barely rose in 2024 while ...

J&J has offered to buy each share of Intra-Cellular for $132, representing a 39% premium to the stock's closing price on Friday. Shares of Intra-Cellular rose 34% to $128 in afternoon trading ...

At the 2025 Consumer Electronics Show (CES), endless tables of gaming equipment, TVs with stretchable screens or suction cup backs, and robots for every possible purpose (we like the little cat ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Two new “pioneering” open-access scale-up facilities focused on advancing cellular agriculture are at the centre of a €12.5m investment grant from the Dutch National Growth Fund for Cellular ...